DE877742T1 - Verfahren zur herstellung von lovastatin - Google Patents
Verfahren zur herstellung von lovastatinInfo
- Publication number
- DE877742T1 DE877742T1 DE0877742T DE96934242T DE877742T1 DE 877742 T1 DE877742 T1 DE 877742T1 DE 0877742 T DE0877742 T DE 0877742T DE 96934242 T DE96934242 T DE 96934242T DE 877742 T1 DE877742 T1 DE 877742T1
- Authority
- DE
- Germany
- Prior art keywords
- lovastatin
- solvent
- acetate
- butyl
- process according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- PCZOHLXUXFIOCF-UHFFFAOYSA-N Monacolin X Natural products C12C(OC(=O)C(C)CC)CC(C)C=C2C=CC(C)C1CCC1CC(O)CC(=O)O1 PCZOHLXUXFIOCF-UHFFFAOYSA-N 0.000 title claims 5
- PCZOHLXUXFIOCF-BXMDZJJMSA-N lovastatin Chemical compound C([C@H]1[C@@H](C)C=CC2=C[C@H](C)C[C@@H]([C@H]12)OC(=O)[C@@H](C)CC)C[C@@H]1C[C@@H](O)CC(=O)O1 PCZOHLXUXFIOCF-BXMDZJJMSA-N 0.000 title claims 5
- 229960004844 lovastatin Drugs 0.000 title claims 5
- QLJODMDSTUBWDW-UHFFFAOYSA-N lovastatin hydroxy acid Natural products C1=CC(C)C(CCC(O)CC(O)CC(O)=O)C2C(OC(=O)C(C)CC)CC(C)C=C21 QLJODMDSTUBWDW-UHFFFAOYSA-N 0.000 title claims 5
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 claims 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 claims 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 2
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 claims 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 claims 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 claims 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 claims 2
- 239000003963 antioxidant agent Substances 0.000 claims 2
- 239000000460 chlorine Substances 0.000 claims 2
- 229910052801 chlorine Inorganic materials 0.000 claims 2
- HCZKYJDFEPMADG-TXEJJXNPSA-N masoprocol Chemical compound C([C@H](C)[C@H](C)CC=1C=C(O)C(O)=CC=1)C1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-TXEJJXNPSA-N 0.000 claims 2
- 239000000203 mixture Substances 0.000 claims 2
- 239000003960 organic solvent Substances 0.000 claims 2
- 239000002904 solvent Substances 0.000 claims 2
- 239000011877 solvent mixture Substances 0.000 claims 2
- -1 -tert-butyl methyl ether-butyl chloride Chemical compound 0.000 claims 1
- UOCLXMDMGBRAIB-UHFFFAOYSA-N 1,1,1-trichloroethane Chemical compound CC(Cl)(Cl)Cl UOCLXMDMGBRAIB-UHFFFAOYSA-N 0.000 claims 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims 1
- KGRVJHAUYBGFFP-UHFFFAOYSA-N 2,2'-Methylenebis(4-methyl-6-tert-butylphenol) Chemical compound CC(C)(C)C1=CC(C)=CC(CC=2C(=C(C=C(C)C=2)C(C)(C)C)O)=C1O KGRVJHAUYBGFFP-UHFFFAOYSA-N 0.000 claims 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 claims 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims 1
- YIISIMWESKLJLI-UHFFFAOYSA-N C(C)(C)CC(C)(C)C.C(C)(=O)OCCC Chemical compound C(C)(C)CC(C)(C)C.C(C)(=O)OCCC YIISIMWESKLJLI-UHFFFAOYSA-N 0.000 claims 1
- CYTYCFOTNPOANT-UHFFFAOYSA-N Perchloroethylene Chemical group ClC(Cl)=C(Cl)Cl CYTYCFOTNPOANT-UHFFFAOYSA-N 0.000 claims 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 claims 1
- XSTXAVWGXDQKEL-UHFFFAOYSA-N Trichloroethylene Chemical group ClC=C(Cl)Cl XSTXAVWGXDQKEL-UHFFFAOYSA-N 0.000 claims 1
- FPACYOBNXBEVPI-UHFFFAOYSA-N acetonitrile;1-chlorobutane Chemical compound CC#N.CCCCCl FPACYOBNXBEVPI-UHFFFAOYSA-N 0.000 claims 1
- 239000003513 alkali Substances 0.000 claims 1
- 230000003078 antioxidant effect Effects 0.000 claims 1
- 230000003115 biocidal effect Effects 0.000 claims 1
- 238000009835 boiling Methods 0.000 claims 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 238000002425 crystallisation Methods 0.000 claims 1
- 230000008025 crystallization Effects 0.000 claims 1
- 238000004042 decolorization Methods 0.000 claims 1
- 238000004090 dissolution Methods 0.000 claims 1
- HCZKYJDFEPMADG-UHFFFAOYSA-N erythro-nordihydroguaiaretic acid Natural products C=1C=C(O)C(O)=CC=1CC(C)C(C)CC1=CC=C(O)C(O)=C1 HCZKYJDFEPMADG-UHFFFAOYSA-N 0.000 claims 1
- DEQYTNZJHKPYEZ-UHFFFAOYSA-N ethyl acetate;heptane Chemical compound CCOC(C)=O.CCCCCCC DEQYTNZJHKPYEZ-UHFFFAOYSA-N 0.000 claims 1
- 238000000605 extraction Methods 0.000 claims 1
- 239000000945 filler Substances 0.000 claims 1
- 239000000706 filtrate Substances 0.000 claims 1
- 238000007273 lactonization reaction Methods 0.000 claims 1
- 229960003951 masoprocol Drugs 0.000 claims 1
- 150000002825 nitriles Chemical class 0.000 claims 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 claims 1
- 239000002244 precipitate Substances 0.000 claims 1
- 238000002360 preparation method Methods 0.000 claims 1
- HHAVHBDPWSUKHZ-UHFFFAOYSA-N propan-2-ol;propan-2-one Chemical compound CC(C)O.CC(C)=O HHAVHBDPWSUKHZ-UHFFFAOYSA-N 0.000 claims 1
- 235000010388 propyl gallate Nutrition 0.000 claims 1
- HRZFUMHJMZEROT-UHFFFAOYSA-L sodium disulfite Chemical compound [Na+].[Na+].[O-]S(=O)S([O-])(=O)=O HRZFUMHJMZEROT-UHFFFAOYSA-L 0.000 claims 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 claims 1
- 235000010262 sodium metabisulphite Nutrition 0.000 claims 1
- 239000007787 solid Substances 0.000 claims 1
- UBOXGVDOUJQMTN-UHFFFAOYSA-N trichloroethylene Natural products ClCC(Cl)Cl UBOXGVDOUJQMTN-UHFFFAOYSA-N 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
- C07D309/16—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D309/28—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D309/30—Oxygen atoms, e.g. delta-lactones
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P17/00—Preparation of heterocyclic carbon compounds with only O, N, S, Se or Te as ring hetero atoms
- C12P17/02—Oxygen as only ring hetero atoms
- C12P17/06—Oxygen as only ring hetero atoms containing a six-membered hetero ring, e.g. fluorescein
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Wood Science & Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Health & Medical Sciences (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Microbiology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Medicines Containing Plant Substances (AREA)
Claims (4)
1. Verfahren zur Herstellung von Lovastatin, dadurch gekennzeichnet, daß Lovastatin aus einer Kulturbouillon
bei einem pH-Wert von 9,5 bis 13,0 gewonnen wird, das Mycel abfiltriert und mit verdünnter Alkalilauge gewaschen
wird, das in einer Feststoffmasse eingeschlossene Lovastatin im Filtrat bei einem pH von 2,5 bis 4,0 in Anwesenheit
eines inerten Füllers, eines Antioxydans und eines 0,1 bis 3,0%igen mit Wasser nicht mischbaren organischen Lösungsmittels
ausgefällt wird, der Niederschlag abfiltriert, azeotrop dehydratisiert und durch Kochen in einem Medium aus
einem chlorhaltigen organischen Lösungsmittel laktonisiert wird, das Lösungsmittel anschließend bis zu einer starken
Einengung des Rückstandes abdestilliert wird, wonach in einem Lösungsmittelgemisch von unterschiedlicher Polarität
gelöst wird, die erhaltene Lösung auf -10 bis -300C abgekühlt
wird, dann das kristallisierte Lovastatin isoliert, getrocknet und anschließend in einem Gemisch aus Nitril und
Wasser unter Entfärbung mit Aluminiumoxid und Aktivkohle und dann in einem Gemisch aus einem Acetat eines C7.9-Niederalkanols
bei einer Temperatur von 0 bis -200C und in Aceton bei -10 bis -300C umkristallisiert wird.
2. Verfahren nach Anspruch 1, dadurch gekennzeichnet , daß als Antioxydantien Butylhydroxytoluol,
Butylhydroxyanisol, Nordihydroguajaretsäure, Gallsäurepropylester,
2,2-Methylen-bis-(6-tert.-butyl-4-methyl-phenol),
Natriumpyrosulfit, Natriumbisulfit, d,1-a-Tocopherylacetat
und Hydrochinon verwendet werden können.
-2- U C
3. Verfahren nach Anspruch 1, dadurch gekennzeichnet , daß als chlorhaltiges Lösungsmittel für
die Extraktion und die Laktonisierung Methylenchlorid, Chloroform, Trichlorethylen, Trichlorethan, Perchlorethylen und
Dichlorethan verwendet werden können.
die Extraktion und die Laktonisierung Methylenchlorid, Chloroform, Trichlorethylen, Trichlorethan, Perchlorethylen und
Dichlorethan verwendet werden können.
4. Verfahren nach Anspruch 1 und Anspruch 2, dadurch gekennzeichnet , daß zur Lösung und Kristallisation
folgende Lösungsmittelgemische verwendet werden können: Isopropanol-Aceton,
Acetonitril-Butylchlorid, Acetonitriltert.-Butylmethylether-Butylchlorid,
Propylacetat-Isooctan
und Ethylacetat-n-Heptan.
und Ethylacetat-n-Heptan.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
BG100197A BG62651B1 (bg) | 1995-12-06 | 1995-12-06 | Метод за изолиране и пречистване на ловастатин |
BG100316A BG63011B1 (bg) | 1996-01-29 | 1996-01-29 | метод за получаване на ловастатин |
PCT/BG1996/000013 WO1997020834A1 (en) | 1995-12-06 | 1996-10-22 | Method of production of lovastatin |
Publications (1)
Publication Number | Publication Date |
---|---|
DE877742T1 true DE877742T1 (de) | 1999-07-22 |
Family
ID=25663364
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69614571T Expired - Fee Related DE69614571T2 (de) | 1995-12-06 | 1996-10-22 | Verfahren zur herstellung von lovastatin |
DE0877742T Pending DE877742T1 (de) | 1995-12-06 | 1996-10-22 | Verfahren zur herstellung von lovastatin |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE69614571T Expired - Fee Related DE69614571T2 (de) | 1995-12-06 | 1996-10-22 | Verfahren zur herstellung von lovastatin |
Country Status (8)
Country | Link |
---|---|
EP (1) | EP0877742B1 (de) |
AU (1) | AU7271696A (de) |
CA (1) | CA2243592C (de) |
DE (2) | DE69614571T2 (de) |
EA (1) | EA000954B1 (de) |
ES (1) | ES2131037T3 (de) |
UA (1) | UA44922C2 (de) |
WO (1) | WO1997020834A1 (de) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SI9800046A (sl) * | 1998-02-18 | 1999-08-31 | LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. | Postopek za pridobivanje inhibitorjev HMG-CoA reduktaze visoke čistosti |
AU1683000A (en) * | 1998-12-10 | 2000-06-26 | Kaneka Corporation | Process for producing simvastatin |
SK282679B6 (sk) * | 1999-04-16 | 2002-11-06 | Biotika, A. S. | Spôsob izolácie lovastatínu z vyfermentovanej pôdy |
IL151583A0 (en) | 2000-03-03 | 2003-04-10 | Plus Chemicals Bv | A process for purifying lovastatin and simvastatin with reduced levels of dimeric impurities |
IN192861B (de) | 2000-06-30 | 2004-05-22 | Ranbaxy Lab Ltd | |
ES2204285B1 (es) * | 2002-05-20 | 2005-03-01 | Ercros Industrial, S.A. | Procedimiento para el aislamiento y purificacion de lovastatina. |
CA2540068C (en) | 2003-10-14 | 2012-05-29 | Lupin Limited | A method for the manufacture of lovastatin |
EP1732912B1 (de) | 2004-03-30 | 2008-11-12 | Lupin Ltd. | Verbessertes verfahren zur herstellung von 4-hydroxypyran-2-onderivaten |
WO2009013764A2 (en) * | 2007-07-24 | 2009-01-29 | Jubilant Organosys Limited | Process for producing 6(r)-[2-(8'(s)-2 ',2 '-dimethylbutyryloxy-2'(s),6'(r)-dimethyl-1,2,6,7', 8',8a'(r)- hexahydronaphthyl-l'(s))ethyl]-4(r)-hydroxy-3,4,5,6- tetrahydro-2h-pyran-2-one |
CN103012344B (zh) * | 2011-09-28 | 2014-11-12 | 北大方正集团有限公司 | 从洛伐他汀结晶母液中回收洛伐他汀的方法 |
EP2597092A1 (de) | 2011-11-24 | 2013-05-29 | Sterling Biotech Limited | Verfahren zum Reinigen von Lovastatin |
CN102875505B (zh) * | 2012-08-02 | 2015-08-05 | 丽珠集团新北江制药股份有限公司 | 一种美伐他汀的提取精制工艺 |
CN106083789A (zh) * | 2016-06-07 | 2016-11-09 | 山东鲁抗医药股份有限公司 | 从发酵液中沉淀分离提取洛伐他汀的方法 |
CN108976190B (zh) * | 2017-12-21 | 2020-09-04 | 北大方正集团有限公司 | 一种从洛伐他汀结晶母液中回收洛伐他汀的方法 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU548996B2 (en) * | 1980-02-04 | 1986-01-09 | Merck & Co., Inc. | Tetrahydro-2h-pyran-2-one derivatives |
HU210867B (en) * | 1992-11-04 | 1995-10-30 | Biogal Gyogyszergyar | Method for extraction and purification of mevinolin from culture medium |
SI9300303A (en) * | 1993-06-08 | 1994-12-31 | Krka Tovarna Zdravil | Process for isolation of hypolipemic effective substance |
-
1996
- 1996-10-22 DE DE69614571T patent/DE69614571T2/de not_active Expired - Fee Related
- 1996-10-22 EA EA199800522A patent/EA000954B1/ru not_active IP Right Cessation
- 1996-10-22 ES ES96934242T patent/ES2131037T3/es not_active Expired - Lifetime
- 1996-10-22 DE DE0877742T patent/DE877742T1/de active Pending
- 1996-10-22 EP EP96934242A patent/EP0877742B1/de not_active Expired - Lifetime
- 1996-10-22 CA CA002243592A patent/CA2243592C/en not_active Expired - Fee Related
- 1996-10-22 UA UA98073524A patent/UA44922C2/uk unknown
- 1996-10-22 AU AU72716/96A patent/AU7271696A/en not_active Abandoned
- 1996-10-22 WO PCT/BG1996/000013 patent/WO1997020834A1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
ES2131037T3 (es) | 2001-12-16 |
DE69614571D1 (de) | 2001-09-20 |
DE69614571T2 (de) | 2002-06-27 |
AU7271696A (en) | 1997-06-27 |
EA000954B1 (ru) | 2000-08-28 |
EP0877742A1 (de) | 1998-11-18 |
UA44922C2 (uk) | 2002-03-15 |
EP0877742B1 (de) | 2001-08-16 |
ES2131037T1 (es) | 1999-07-16 |
CA2243592A1 (en) | 1997-06-12 |
EA199800522A1 (ru) | 1999-02-25 |
WO1997020834A1 (en) | 1997-06-12 |
CA2243592C (en) | 2001-12-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DE877742T1 (de) | Verfahren zur herstellung von lovastatin | |
Taniguchi et al. | Stereochemical studies—XXX: Stereoselective synthesis of D-ribose from L-glutamic acid | |
DE1795763C3 (de) | Verfahren zur Herstellung von Vincaleukoblastin- und Leurocristinderivaten | |
DE2902466C2 (de) | ||
JP2004510817A5 (de) | ||
IE780760L (en) | Cephalosporin antibiotics | |
KR840006659A (ko) | 6,7-디히드로-5,8-디메틸-9-플루오로-1-옥소-1H,5H-벤조[ij]퀴놀리진-2-카르복실산 및 그 유도체의 제조방법 | |
US3846490A (en) | Method of producing zeta-aminolevulinic acid hydrochloride | |
KR940009194A (ko) | 클라불란산 칼륨염의 제조 방법 | |
DE3309159A1 (de) | Neue optisch aktive chromanderivate, verfahren zu deren herstellung sowie neue zwischenprodukte | |
DE2153600A1 (de) | ||
Cooke et al. | Colouring matters of Australian Plants. V. Haemocorin: The chemistry of the Aglycone | |
DE2443109C2 (de) | Verfahren zur Gewinnung von L-Phenylalanin-methylester | |
DE2167181B1 (de) | Methyl-N-acetyl-6,7-aziridino-6-desamino-7-desoxy-2,3,4-tri-0-acetyl-alpha-thiolincosaminid und Verfahren zu dessen Herstellung | |
DE2518974C2 (de) | Verfahren zur Herstellung von Sorbinsäure | |
FI922740A (fi) | Foerfarande foer avlaegsning av aceton fraon en blandning, som innehaoller aceton, metylacetat och metyljodid | |
DE1134981B (de) | Verfahren zur Herstellung von N-substituierten 3-Methoxy-4-carbamidomethoxyphenylessigsaeurealkyl- und alkenylestern | |
KR100325558B1 (ko) | 7-클로로퀴놀린-8-카르복실산의정제방법 | |
DE2053188B2 (de) | Verfahren zur Herstellung von Niederalkylestern des a -L-Asparagyl- L-phenylalanins | |
GB958064A (en) | Method of purifying sugar esters | |
AT261592B (de) | Verfahren zur Herstellung L-(-)-α-Methyl-β-(3,4-dihydroxyphenyl)-alanin | |
DE2103051C3 (de) | Verfahren zur Reinigung von aus Keten und Crotonaldehyd hergestellter Sorbinsäure | |
GB1198414A (en) | Process for the Preparation of 4-acyloxybutyric Acid Esters | |
DE1817716A1 (de) | Acrylate und Methacrylate | |
JPS5779185A (en) | Manufacture of n-valerianic acid or its ester |